Thomas Civik
CIK 1723092 · Interim CEO · last filed 2026-02-05
Thomas Civik is an Interim CEO who has filed 18 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for PYXS, was dated Feb 5, 2026. Across all open-market trades the lifetime net is +$410.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $390.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$390.5K
4
18
$410.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PYXS | Interim CEO | 221,886 | $1.76 | $390.5K | $200.0K | 7 | 2026-02-05 |
| Repare Therapeutics Inc. (RPTX) Delisted | Director | 0 | $2.65 | $0 | $210.6K | 6 | 2026-01-28 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | President and CEO | 0 | $38.00 | $0 | $0 | 3 | 2021-04-19 |
| Foundation Medicine, Inc. (FMI) Delisted | Chief Commercial Officer | 33,421 | — | — | $0 | 1 | 2018-01-03 |
Recent Filings
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-05 | PYXS | Grant (A) | — | $0 | EDGAR |
| 2026-01-28 | Repare Therapeutics Inc. (RPTX) Delisted | Disp (D) | −7,500 | $0 | EDGAR |
| 2025-04-02 | PYXS | Grant (A) | — | $0 | EDGAR |
| 2024-06-20 | Repare Therapeutics Inc. (RPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-28 | PYXS | Grant (A) | — | $0 | EDGAR |
| 2023-06-12 | Repare Therapeutics Inc. (RPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-28 | PYXS | Grant (A) | +139,355 | $0 | EDGAR |
| 2022-05-16 | Repare Therapeutics Inc. (RPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-04 | PYXS | Grant (A) | +66,831 | $0 | EDGAR |
| 2021-11-19 | PYXS | Buy (P) | +15,700 | $200.0K | EDGAR |